These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30902074)

  • 1. Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts.
    Mendieta I; Nuñez-Anita RE; Nava-Villalba M; Zambrano-Estrada X; Delgado-González E; Anguiano B; Aceves C
    BMC Cancer; 2019 Mar; 19(1):261. PubMed ID: 30902074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
    Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
    Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
    Zambrano-Estrada X; Landaverde-Quiroz B; Dueñas-Bocanegra AA; De Paz-Campos MA; Hernández-Alberto G; Solorio-Perusquia B; Trejo-Mandujano M; Pérez-Guerrero L; Delgado-González E; Anguiano B; Aceves C
    BMC Vet Res; 2018 Mar; 14(1):87. PubMed ID: 29530037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.
    Su Y; Vanderlaag K; Ireland C; Ortiz J; Grage H; Safe S; Frankel AE
    Breast Cancer Res; 2007; 9(4):R56. PubMed ID: 17764562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
    Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
    BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models.
    Álvarez-León W; Mendieta I; Delgado-González E; Anguiano B; Aceves C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR).
    Aceves C; García-Solís P; Arroyo-Helguera O; Vega-Riveroll L; Delgado G; Anguiano B
    Mol Cancer; 2009 Jun; 8():33. PubMed ID: 19500378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
    Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
    Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection.
    Alfaro Y; Delgado G; Cárabez A; Anguiano B; Aceves C
    Mol Cancer; 2013 May; 12():45. PubMed ID: 23705792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer.
    Nuñez-Anita RE; Arroyo-Helguera O; Cajero-Juárez M; López-Bojorquez L; Aceves C
    Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):34-42. PubMed ID: 19443248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
    Go RE; Kim CW; Jeon SY; Byun YS; Jeung EB; Nam KH; Choi KC
    Environ Toxicol; 2017 Apr; 32(4):1439-1454. PubMed ID: 27539251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
    Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
    Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHEA increases epithelial markers and decreases mesenchymal proteins in breast cancer cells and reduces xenograft growth.
    Colín-Val Z; González-Puertos VY; Mendoza-Milla C; Gómez EO; Huesca-Gómez C; López-Marure R
    Toxicol Appl Pharmacol; 2017 Oct; 333():26-34. PubMed ID: 28803991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shock Wave Application Increases the Antineoplastic Effect of Molecular Iodine Supplement in Breast Cancer Xenografts.
    Peña M; Delgado-Gonzalez E; López-Marín LM; Millán-Chiu BE; Fernández F; Rodriguez-Castelan J; Muñoz-Torres C; Carrasco G; Anguiano B; Loske AM; Aceves C
    Ultrasound Med Biol; 2020 Mar; 46(3):649-659. PubMed ID: 31883734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-iodolactone, key mediator of antitumoral properties of iodine.
    Nava-Villalba M; Aceves C
    Prostaglandins Other Lipid Mediat; 2014 Aug; 112():27-33. PubMed ID: 25018052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
    Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.